子宫内膜异位症子宫切除术后按卵巢去留状态比较再手术与疼痛相关结局
该研究基于加拿大不列颠哥伦比亚省2001至2016年4489例19至50岁因子宫内膜异位症行子宫切除术的患者,比较保留双卵巢、单侧输卵管卵巢切除及双侧输卵管卵巢切除三组的再手术率与疼痛相关医疗服务使用。随访中位10年,保留双卵巢组再手术率13%高于双侧输卵管卵巢切除组5%(P<.0001),但两组在因内异症或盆腔痛就诊、阿片类药物处方天数及激素抑制药物使用上相似。
要点
- 保留双卵巢组再手术率13%高于双侧输卵管卵巢切除组5%(P<.0001),最常见再手术为卵巢切除或粘连松解。
- 三组因子宫内膜异位症或盆腔痛就诊率及阿片类药物处方天数非常相似。
- 双侧输卵管卵巢切除组术后3至12个月60.6%患者至少配取1次激素替代治疗处方。
核心结论
- 双侧输卵管卵巢切除组再手术率低于保留一侧或双侧卵巢组,但次要结局差异很小,提示术后持续盆腔痛可能不因卵巢保留状态而实质不同。
- 作者认为因子宫内膜异位症行子宫切除术时应强烈考虑保留卵巢。
研究设计与样本
- 基于人群的回顾性队列研究,纳入加拿大不列颠哥伦比亚省2001至2016年因子宫内膜异位症行子宫切除术的4489例19至50岁患者。
- 按索引手术分为子宫切除 alone(保留双卵巢)、子宫切除加单侧输卵管卵巢切除、子宫切除加双侧输卵管卵巢切除三组。
- 主要结局为再手术率;次要结局于术后3至12个月及1至5年测量,包括因内异症和盆腔痛就诊、阿片类药物处方配取、激素抑制药物及激素替代治疗使用。
主要发现
- 随访中位10年(四分位距6.1至14.3年),全部患者中89.5%至随访结束时未再手术。
- 保留双卵巢组至少1次再手术者13%,高于双侧输卵管卵巢切除组的5%(P<.0001)。
- 敏感性分析剔除作为再手术的卵巢切除后,保留双卵巢组至少1次再手术者6%,双侧输卵管卵巢切除组3%,差异部分减弱。
- 三组因内异症或盆腔痛就诊率及阿片类药物处方天数非常相似,激素抑制药物使用率亦相似。
- 双侧输卵管卵巢切除组术后3至12个月60.6%患者至少配取1次激素替代治疗处方。
临床怎么用
- 作者认为因子宫内膜异位症行子宫切除术时应强烈考虑保留卵巢。
- 双侧输卵管卵巢切除术后约40%患者未配取激素替代治疗处方,作者指出这可能对早发手术绝经者造成显著健康后果。
局限性
- 无法按子宫内膜异位症分期对患者分层,也无法确定内异症分期或附件病变或深部内异症对结局的影响。
- 双侧输卵管卵巢切除术后约40%患者未配取激素替代治疗处方,可能对早发手术绝经者造成显著健康后果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: More research is needed that compares the outcomes between those who underwent a hysterectomy for endometriosis with conservation of one or both ovaries and those who underwent a hysterectomy with bilateral salpingo-oophorectomy. OBJECTIVE: This study aimed to compare the rate and types of reoperations (primary outcome) and use of other pain-related health services (secondary outcomes) among people who underwent a hysterectomy with conservation of both ovaries, those who underwent a hysterectomy with unilateral salpingo-oophorectomy, and those who underwent a hysterectomy with bilateral salpingo-oophorectomy. STUDY DESIGN: This was a population-based, retrospective cohort study of 4489 patients aged 19 to 50 years in British Columbia, Canada, who underwent a hysterectomy for endometriosis between 2001 and 2016. Index surgeries were classified as hysterectomy alone (conservation of both ovaries), hysterectomy with unilateral salpingo-oophorectomy, or hysterectomy with bilateral salpingo-oophorectomy. Reoperation rate was the primary outcome. Secondary outcomes (measured at 3-12 months and 1-5 years after hysterectomy) included physician visits for endometriosis and pelvic pain, prescriptions filled for opioids, and use of hormonal suppression medications and hormone replacement therapy. RESULTS: Reoperation rates were low across all groups, with 89.5% of all patients remaining reoperation free by the end of follow-up (median of 10 years; interquartile range, 6.1-14.3 years). Patients who underwent a hysterectomy alone were more likely to undergo at least 1 reoperation when compared with those who underwent a hysterectomy with bilateral salpingo-oophorectomy (13% vs 5%; P<.0001), most commonly an oophorectomy or adhesiolysis. When oophorectomy as reoperation was removed in a sensitivity analysis, this difference was partially attenuated (6% of hysterectomy alone group vs 3% of hysterectomy with bilateral salpingo-oophorectomy group undergoing at least 1 reoperation). All groups were very similar in terms of rates of physician visits for endometriosis or pelvic pain and the number of days of opioid prescriptions filled. Furthermore, the rate of hormonal suppression medication use was similar among the groups, whereas the rate of prescriptions filled for hormone replacement therapy after hysterectomy with bilateral salpingo-oophorectomy was 60.6% of patients who filled at least 1 prescription at 3 to 12 months after index surgery. CONCLUSION: Patients who underwent a hysterectomy with bilateral salpingo-oophorectomy had a lower reoperation rate than those who underwent a hysterectomy with conservation of one or both ovaries. However, there was little difference between the groups for the secondary outcomes measured, including physician visits for endometriosis and pelvic pain, opioid use, and use of hormonal suppression medications, suggesting that persistent pelvic pain after hysterectomy for endometriosis may not differ substantively based on ovarian conservation status. One limitation was the inability to stratify patients by stage of endometriosis or to determine the impact of endometriosis stage or the presence of adnexal disease or deep endometriosis on the outcomes. Moreover, hormone replacement therapy prescriptions was not filled by about 40% of patients after hysterectomy with bilateral salpingo-oophorectomy, which may have significant health consequences for these individuals undergoing premature surgical menopause. Therefore, strong consideration should be given to ovarian conservation at the time of hysterectomy for endometriosis.
引用
- Long AJ, Kaur P, Lukey A, et al. Reoperation and pain-related outcomes after hysterectomy for endometriosis by oophorectomy status. Am J Obstet Gynecol. 2022. PMID: 36029832. doi:10.1016/j.ajog.2022.08.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。